New drug combo offers hope for rare Pregnancy-Related cancer

This study tests whether combining two drugs, camrelizumab and apatinib, with standard chemotherapy can help women with a rare but aggressive pregnancy-related cancer called gestational trophoblastic neoplasia (GTN). The trial includes two groups: those with ultra high-risk disease who haven't had treatment yet, and those whose cancer has returned or not responded to prior therapies. The goal is to see if this combination can shrink or eliminate tumors by measuring blood levels of a key marker (β-hCG).